Yaakov Nahmias

Prof. Yaakov “Koby” Nahmias is a bioengineer and innovator, whose breakthroughs ranged from the first 3D printing of cells to the first commercial human-on-chip technology. He is a Magna Cum Laude graduate of the Technion, Israel Institute of Technology, and is the founding director of the Grass Center for Bioengineering of the Hebrew University of Jerusalem. Nahmias is a recipient of a NIH career award, two European Research Council (ERC) grants, the Kaye Innovation Award, and the prestigious Rappaport Prize in Biomedical Research. He is the first scientist outside Britain to win the Rosetrees Trust Prize. Nahmias is a fellow of both the prestigious American Institute for Medical and Biological Engineering (AIMBE) and the British Royal Society of Medicine (RSM). He is an editorial board member of the Annual Reviews for Biomedical Engineering, and a long-standing member of the European Research Council LS9 Biotechnology committee. Nahmias is the founding director of BioDesign-Israel, an entrepreneurship program sponsored by Boston Scientific that spun off several medical device companies including Guide In Medical, CardioVia, and VenoVision.